Krystal Dawn Shook, APRN-BC in Bartlesville, OK - Family Medicine

Krystal Dawn Shook, APRN-BC is a Family Medicine based in Bartlesville, Oklahoma. Krystal Dawn Shook is licensed to practice in Oklahoma (license number 200745) and her current practice location is 1217 Guinn Ln, Bartlesville, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (918) 214-6960.

NPI number for Krystal Dawn Shook is 1457949398 and her current mailing address is 1217 Guinn Ln, Bartlesville, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1457949398.

Contact Information

	Krystal Dawn Shook, APRN-BC
	1217 Guinn Ln, Bartlesville, OK 74006-5607
	(918) 214-6960
	Not Available

Provider's Profile

Full Name	Krystal Dawn Shook
Gender	Female
Speciality	Family Medicine
Location	1217 Guinn Ln, Bartlesville, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1457949398
Provider Enumeration Date: 01/06/2021
Last Update Date: 04/19/2023

Medical Identifiers

Medical identifiers for Krystal Dawn Shook such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1457949398	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	R0123042 (Oklahoma)	Secondary
207Q00000X	Family Medicine	200745 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Krystal Dawn Shook is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Krystal Dawn Shook, APRN-BC 1217 Guinn Ln, Bartlesville, OK 74006-5607 Ph: (918) 214-6960	Krystal Dawn Shook, APRN-BC 1217 Guinn Ln, Bartlesville, OK 74006-5607 Ph: (918) 214-6960

News Archive

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

'Digital twins' of individual patients may help find best medication to each patient

Advanced computer models of diseases can be used to improve diagnosis and treatment. The goal is to develop the models to "digital twins" of individual patients.

HUCPVC cell therapy more effective in restoring heart function after myocardial infarction

A study published this month by researchers at the University of Toronto and Toronto's Princess Margaret Hospital has shown that cells derived from the umbilical cord, "Human Umbilical Cord PeriVascular Cells" (HUCPVCs), are more effective in restoring heart function after an acute myocardial infarction (in common parlance, a heart attack) in a pre-clinical model than a similar cell population derived from bone marrow.

Arizona State University researchers to use laws of physics for cancer research

Instead of killing cancer cells, researchers at Arizona State University will use the laws of physics to figure out how to control them. And, rather than treating cancer as a disease and seeking a cure, ASU scientists will view cancer cells as physical objects and study them the way a physicist would, using simple variables like temperature, pressure and force.

New U of T study shows that acetaminophen could impede error-detection in the brain

It's been known for more than a century that acetaminophen is an effective painkiller, but according to a new U of T study it could also be impeding error-detection in the brain.

Krystal Dawn Shook, APRN-BC - Family Medicine in Bartlesville, OK